TGTX
TG Therapeutics Inc
56.50$
+1.1%
vs. previous close
Closing price · As of: Sep 17, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -73.5% | +44.4% | +15.7% | +14.2% | +29.0% | +11.7% | +16.8% | +14.6% | +19.1% | +6.4% | +17.3% | – | |
| – | +126.4% | -30.5% | +50.4% | +12.5% | +64.9% | +0.9% | +21.9% | +48.7% | +35.5% | -12.1% | +22.9% | – | |
| – | -77.8% | +60.9% | +12.4% | +14.4% | +24.5% | +13.5% | +16.0% | +9.3% | +15.6% | +11.0% | +16.2% | – | |
| – | +18.3% | +87.5% | -46.3% | +14.7% | +18.6% | +94.2% | -31.4% | +28.6% | +0.8% | +17.5% | +97.0% | – | |
| – | +3.8% | +1.7% | +12.2% | +8.2% | -7.2% | +29.2% | +10.4% | +13.9% | -0.9% | +40.6% | -6.9% | – | |
| – | +2.1% | +38.6% | -16.2% | +10.2% | +1.2% | +53.9% | -9.6% | +19.3% | -0.2% | +31.4% | +29.9% | – | |
| – | -110.9% | – | – | +41.0% | +140.9% | -71.2% | +304.1% | -15.7% | +72.0% | -31.1% | -37.7% | – | |
| – | -34.5% | -5.9% | +73.8% | +172.4% | -34.8% | -4.3% | -0.6% | +0.1% | -2.8% | +17.3% | +116.2% | – | |
| – | -112.3% | – | – | -34.8% | +496.4% | -78.5% | +465.5% | -16.2% | +74.0% | -54.8% | -49.7% | – | |
| – | – | -92.6% | -1,231.0% | – | +446.9% | -80.8% | +569.9% | -13,454.8% | – | -97.3% | +318.6% | – | |
| – | -112.7% | – | – | -43.6% | +501.3% | -78.3% | +457.1% | +1,286.8% | -94.1% | -14.2% | -60.7% | – | |
| – | -109.8% | – | – | +43.1% | +114.8% | -62.3% | +206.9% | -13.3% | +58.1% | -45.6% | -22.9% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.